Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies

OBJECTIVES: Bladder cancer (BlCa) is the tenth most frequent malignancy worldwide and the costliest to treat and monitor. Muscle‐invasive BlCa (MIBC) has a dismal prognosis, entailing the need for alternative therapies for the standard radical cystectomy. Checkpoint blockade immunotherapy has been a...

Descripción completa

Detalles Bibliográficos
Autores principales: Viveiros, Nicole, Flores, Bianca CT, Lobo, João, Martins‐Lima, Cláudia, Cantante, Mariana, Lopes, Paula, Deantonio, Cecilia, Palu, Cintia, Sainson, Richard CA, Henrique, Rui, Jerónimo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440624/
https://www.ncbi.nlm.nih.gov/pubmed/36092481
http://dx.doi.org/10.1002/cti2.1402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440624/
https://www.ncbi.nlm.nih.gov/pubmed/36092481
http://dx.doi.org/10.1002/cti2.1402

Ejemplares similares